Ciprofloxacin dry powder for inhalation regulatory update

FDA granted Orphan Drug designation to Bayer's ciprofloxacin dry powder for inhalation (DPI) to treat non-cystic fibrosis bronchiectasis. Ciprofloxacin DPI is in Phase III testing as a chronic intermi...